As America’s opioid epidemic continues, prescription drug monitoring programs (PDMPs) are critical to providing comprehensive and timely data on controlled substance prescriptions, enabling clinicians to identify patients who may be at risk for substance use disorder.

As of 2023, all 50 states and Washington D.C. have operational PDMPs. While states have taken great strides to advance PDMPs, the growing need to turn the tide on the opioid epidemic has them now focusing on early intervention and treatment strategies.

Download this white paper to learn about:

  • Latest changes to PDMPs in 2025
  • Key benefits of comprehensive PDMP utilization
  • New strategies to increase the effectiveness of PDMPs

©2025 Behavioral Health Business 

Your information will be shared with Bamboo Health and may be used to inform you about products and services offered by Behavioral Health Business and Bamboo Health.

This White Paper was created in partnership with

Bamboo Health Logo

WHITE PAPER

The Power of PDMPs
Advancing Patient Safety Through Better Utilization of Prescription Drug Monitoring Programs

Bamboo Health Logo